BDR Pharmaceuticals
  • Home
    • About BDR
    • CMD Profile
    • News
    • Blogs
    • Our Strengths
    • Facilities
    • Press Release
    • Company Policies
    • CSR Sustainability
    • Mission & Vision
    • Ethical Marketing Division
    • Milestones
    • Global Presence
    • Board of Directors
    About Us
  • Products
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
    Expertise
    • Culture
    • Job Openings
    Careers
  • Investors
  • Contact
  1. Home
  2. Press Release

Press Release

Innovative Breakthroughs in Pharmaceuticals: Press Releases and Updates

news ET Healthworld
Exclusive Story Jul 01, 2024

BDR Pharma to commercialise furmecil anti-cancer-drug for advanced gastric cancer

Read More
news MoneyControl
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Times Of India
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Business Today
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Business Standard
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Mint
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›

Print Media Coverage

ET Healthworld

Indian pharma optimistic, despite no Budget announcement

Financial Express

Share Market Highlights: Nifty gains almost 160 pts, Sensex reclaims 61000 at close; Adani Ent shares jump 9%

The Indian Express

Analysts see another 25 bps rate hike as Jan’s CPI inflation breaches RBI's tolerance limit

Mint

WPI inflation cools to 24-month low of 4.73% in January

Hindustan Times

Budget 2023: What healthcare, manufacturing sectors expect from FM Sitharaman

Mint

Union Budget 2023: What the healthcare sector expects from FM Sitharaman

Express Pharma

BDR Pharmaceuticals focusing on NDDS, Complex molecules in big way

Hurun Magazine

Bridging gaps in healthcare: A vision for affordable and accessible treatments

Pharmabiz Annual Issue Magazine

BDR Pharmaceuticals focusing on NDDS, Complex molecules in big way

eHealth Magazine

Embracing patient-centric care and sustainable practices in biopharmaceuticals (Edition) - Dubai

The Hindu Business Line

WPI inflation hits 8-year low of (-)4.12% in June on cheaper food (Editions) - Chennai, Hyderabad, Bangalore, New Delhi, Mumbai, Kolkata

The Statesmen

India’s wholesale inflation falls to 1.34 per cent

Sandesh

BDR Pharmaceuticals Launches T20 Cricket Tournament for Pharma Companies

Gujarat Samachar

BDR Pharmaceuticals Launches T20 Cricket Tournament for Pharma Companies

Samay Express

BDR Pharma launches generic antibiotic range medicine, Ceftazidime Avibactum

  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ›
Discover Previous
News Section
awards-cta
Discover Next
Ethical Marketing
certification-cta
footer-logo

BDR is a “niche” player in both global and domestic arena

Company
About BDR Milestones Our Mission & Vision Our Achivements CMD Profile
Expertise
Innovation & Technology Regulatory Research & Development IPR Quality Policy Contract Manufacturing
Quick Links
Home Products News Careers Contact
Registered Office

BDR Pharmaceuticals Internationals Pvt. Ltd. Registered Office, 407/408, Sharda Chambers, New Marine Lines, Mumbai 400020, India.

+91-22-40560560
Corporate Office

Grievance officer: Mr. Pawan Srivastava

Ombudsman, 6, Engineering Centre, 9 Mathew Road, Opera House, Mumbai- 400004, India.

+91-22-40560560
ombudsman@bdrpharma.com

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at the buyer's risk. Products currently covered by valid patents in India are offered for R&D purpose in accordance with Section 107(A) of the Patents Act, 1970.

© BDR Pharmaceuticals International Pvt. Ltd, All Rights Reserved. Designed By Ideamagix.

Terms & Conditions | Privacy Policy

  • Home
  • About Us
    • Overview
    • Our Strengths
    • Achievements
    • CSR Sustainability
    • Milestones
    • CMD Profile
    • Facilities
    • Mission & Vision
    • Global Presence
    • News
    • Press Release
    • Ethical Marketing Division
    • Board Of Directors
    • Blogs
    • Company Policies
  • Products
  • Expertise
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
  • Careers
    • Culture
    • Job Openings
  • Investors
  • Contact